Filing metadata

Accession number
0001104659-12-013318
Form type
Form 4
Filer
Anthera Pharmaceuticals Inc
CIK
CIK 1316175
Filed
Feb 27, 2012
Reporting period
Feb 23, 2012
Description
Insider transaction

Explore SEC Filings Hub